作者: Andrea Martoni , Alessandra Longhi , Nadia Canova , Franco Pannuti
DOI: 10.1159/000226884
关键词: Internal medicine 、 Advanced breast 、 Gynecology 、 Medroxyprogesterone acetate 、 Breast cancer 、 Cancer 、 First line therapy 、 Randomized controlled trial 、 Oncology 、 Medicine 、 Oophorectomy
摘要: Forty premenopausal patients with advanced breast cancer entered a prospective and randomized study in which high-dose medroyxprogesterone acetate (HD MAP) oophorectomy (OPX) were compared. All th